Home › Research › Prevention trials
SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes
Julia-Sophia Scheuermann, Petra Scheerbaum, Yu Liu, Yaping Ding, Jianwen Lu, Ming Zhong, Jian Su, Olaf Gefeller et al.. BMJ Open, 2025-04-01
Topic: Risk, prevention and care in population studies
This disease is associated with numerous restrictions for those affected but also for caregivers and society. Results will be published in peer-reviewed scientific journals and conference presentations.
Key findings
- This disease is associated with numerous restrictions for those affected but also for caregivers and society.
- Results will be published in peer-reviewed scientific journals and conference presentations.
Why it matters
This is a protocol for a randomized controlled trial to evaluate a Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes. No results are reported yet, so it provides no evidence about treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designrandomized controlled trial
- Participants200
- Evidence strengthHigh
How this study scored 55/100
Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (BMJ Open) |
| Journal's citation record | 2 / 4 | BMJ Open: journal h-index 240 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomised controlled trial |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 200 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 1 / 2 | Randomised (as stated in the record) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 1 / 6 | Cited 0.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author André Kratzer: h-index 8 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Friedrich-Alexander-Universität Erlangen-Nürnberg: institution h-index 901 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40306986) |
| Free to read | 2 / 2 | Free to read |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
APA 7th
Scheuermann, J.-S., Scheerbaum, P., Liu, Y., Ding, Y., Lu, J., Zhong, M., et al. (2025). SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes. BMJ Open. https://doi.org/10.1136/bmjopen-2024-093618
Vancouver
Scheuermann J.-S, Scheerbaum P, Liu Y, Ding Y, Lu J, Zhong M, et al. SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes. BMJ Open. 2025. doi:10.1136/bmjopen-2024-093618. PMID: 40306986.
BibTeX
@article{scheuermann2025-40306986,
author = {Scheuermann, Julia-Sophia and Scheerbaum, Petra and Liu, Yu and Ding, Yaping and Lu, Jianwen and Zhong, Ming and Su, Jian and Gefeller, Olaf and others},
title = {{SinoMAKS—protocol of a randomised controlled trial to evaluate the Chinese version of the non-pharmacological, multimodal MAKS intervention for people with mild to moderate dementia in Chinese nursing homes}},
journal = {BMJ Open},
year = {2025},
doi = {10.1136/bmjopen-2024-093618},
pmid = {40306986},
url = {https://doi.org/10.1136/bmjopen-2024-093618}
}
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Prevention trials
Also tagged “double-blind”
783 studies in the library carry the topic tag “double-blind”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.